-
AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
2024 Jun 03, 3:32pm | 936AbbVie (NYSE: ABBV) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending approval of Skyrizi (risankizumab) in the EU to treat adults with moderately to severely active ulcerative...
-
Hormel Foods Q2 Earnings Beat Estimates
2024 May 30, 1:05pm | 656Hormel Foods (NYSE: HRL) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.40 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise...
-
Intuitive Surgical Stock Gains 20% YTD: Here's Why
2024 May 28, 3:57pm | 912Intuitive Surgical (NASDAQ: ISRG) witnessed strong momentum in the year-to-date period. Shares of the company have gained 20% compared with 8.2% growth of the industry in the same time frame. The S&P 500 Composite has risen 11.5% during the same period. With healthy fundamentals...
Coverage of Earnings Beats.